Biofilm's Impact on Inflammatory Bowel Diseases
- PMID: 37868553
- PMCID: PMC10585119
- DOI: 10.7759/cureus.45510
Biofilm's Impact on Inflammatory Bowel Diseases
Abstract
The colon has a large surface area covered with a thick mucus coating. Colon's biomass consists of about 1,012 colony-forming units per gram of feces and 500-1,000 distinct bacterial species. The term inflammatory bowel disease (IBD) indicates the collection of intestinal illnesses in which the digestive system (esophagus, large intestine, mouth, stomach, and small intestine) experiences persistent inflammation. IBD development is influenced by environmental (infections, stress, and nutrition) and genetic factors. The microbes present in gut microbiota help maintain intestinal homeostasis and support immune and epithelial cell growth, differentiation, as well as proliferation. It has been discovered that a variety of variables and microorganisms are crucial for the development of biofilms and mucosal colonization during IBD. An extracellular matrix formed by bacteria supports biofilm production in our digestive system and harms the host's immunological response. Irritable bowel syndrome (IBS) and IBD considerably affect human socioeconomic well-being and the standard of living. IBD is a serious public health issue, affecting millions of people across the globe. The gut microbiome may significantly influence IBS pathogenesis, even though few diagnostic and treatment options are available. As a result, current research focuses more on disrupting biofilm in IBD patients and stresses primarily on drugs that help improve the quality of life for human well-being. We evaluate studies on IBD and bacterial biofilm to add fresh insights into the existing state of knowledge of biofilm formation in IBD, incidence of IBD patients, molecular level of investigations, bacteria that are involved in the formation of biofilm, and present and down the line regimens and probiotics. Planning advanced ways to control and eradicate bacteria in biofilms should be the primary goal to add fresh insights into generating innovative diagnostic and alternative therapy options for IBD.
Keywords: crohns disease; drugs for inflammatory bowel disease; epidemiology of inflammatory bowel disease; human gut microbiota; ulcerative colitis.
Copyright © 2023, Palandurkar et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
Similar articles
-
Gastrointestinal Biofilms: Endoscopic Detection, Disease Relevance, and Therapeutic Strategies.Gastroenterology. 2024 Jun 12:S0016-5085(24)05054-6. doi: 10.1053/j.gastro.2024.04.032. Online ahead of print. Gastroenterology. 2024. PMID: 38876174 Review.
-
The Impact of Inflammatory Bowel Disease in Canada 2018: Children and Adolescents with IBD.J Can Assoc Gastroenterol. 2019 Feb;2(Suppl 1):S49-S67. doi: 10.1093/jcag/gwy056. Epub 2018 Nov 2. J Can Assoc Gastroenterol. 2019. PMID: 31294385 Free PMC article.
-
Gut biofilm forming bacteria in inflammatory bowel disease.Microb Pathog. 2017 Nov;112:5-14. doi: 10.1016/j.micpath.2017.09.041. Epub 2017 Sep 20. Microb Pathog. 2017. PMID: 28942174 Review.
-
The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.Microbiol Spectr. 2015 Jun;3(3). doi: 10.1128/microbiolspec.MBP-0008-2014. Microbiol Spectr. 2015. PMID: 26185088
-
Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.Dan Med J. 2015 Jan;62(1):B4973. Dan Med J. 2015. PMID: 25557335 Review.
Cited by
-
Bacterial membrane vesicles in the pathogenesis and treatment of inflammatory bowel disease.Gut Microbes. 2024 Jan-Dec;16(1):2341670. doi: 10.1080/19490976.2024.2341670. Epub 2024 Apr 26. Gut Microbes. 2024. PMID: 38666762 Free PMC article. Review.
-
Bacteria Living in Biofilms in Fluids: Could Chemical Antibiofilm Pretreatment of Culture Represent a Paradigm Shift in Diagnostics?Microorganisms. 2024 Jan 26;12(2):259. doi: 10.3390/microorganisms12020259. Microorganisms. 2024. PMID: 38399663 Free PMC article. Review.
References
-
- Diagnosis and therapeutic management of extra-intestinal manifestations of inflammatory bowel disease. Trikudanathan G, Venkatesh PG, Navaneethan U. Drugs. 2012;72:2333–2349. - PubMed
-
- The gut microbiota in inflammatory bowel disease. Macfarlane GT, Blackett KL, Nakayama T, Steed H, Macfarlane S. Curr Pharm Des. 2009;15:1528–1536. - PubMed
-
- Inflammatory bowel disease, gut bacteria and probiotic therapy. Reiff C, Kelly D. Int J Med Microbiol. 2010;300:25–33. - PubMed
-
- Mucosal flora in Crohn's disease and ulcerative colitis - an overview. Swidsinski A, Loening-Baucke V, Herber A. https://pubmed.ncbi.nlm.nih.gov/20224153/ J Physiol Pharmacol. 2009;60:61–71. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials